Latest papers

Organelle stress sensors and cell death mechanisms in neurodegenerative diseases.

Conformational preferences of non-polar amino acid residues: an additional factor in amyloid formation.

Soluble factors from IL-1β-stimulated astrocytes activate NR1a/NR2B receptors: implications for HIV-1-induced neurodegeneration.

Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease.

Cell death or survival: The double-edged sword of environmental and occupational toxicity.

Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases.

Recent developments in the inhibitors of neuroinflammation and neurodegeneration: inflammatory oxidative enzymes as a drug target.

Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders.

AFFITOME® technology in neurodegenerative diseases: the doubling advantage.

Microglial activation and chronic neurodegeneration.

Modern challenges in therapeutic protein production.

Potential therapeutic targets for neurodegenerative diseases: lessons learned from calorie restriction.

The role of PGC-1α in the pathogenesis of neurodegenerative disorders.

Sirtuins: common targets in aging and in neurodegeneration.

ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders.

[Stem cell therapy for neurodegenerative disorders]

5-hydroxytryptamine subtype 6 receptor modulators: a patent survey.

Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity.

[Neurologic and psychiatric implications of apathy]

Low-molecular-mass peptides from the venom of the Amazonian viper Bothrops atrox protect against brain mitochondrial swelling in rat: potential for neuroprotection.